- Report
- August 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- August 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- August 2024
- 138 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- September 2023
- 303 Pages
Global
From €4866EUR$5,298USD£3,950GBP
- Report
- January 2024
- 213 Pages
Global
From €4421EUR$4,650USD£3,714GBP
- Report
- September 2022
- 110 Pages
Global
From €5229EUR$5,500USD£4,393GBP
- Report
- February 2024
- 202 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- October 2022
- 194 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- November 2020
- 217 Pages
Global
From €3803EUR$4,000USD£3,195GBP
- Report
- November 2019
- 169 Pages
Global
From €1307EUR$1,375USD£1,098GBP
€2614EUR$2,750USD£2,196GBP
- Report
- August 2023
- 370 Pages
Global
From €2367EUR$2,490USD£1,989GBP
- Report
- January 2022
- 150 Pages
Global
From €2852EUR$3,000USD£2,396GBP
- Report
- October 2024
- 80 Pages
Vietnam
From €3422EUR$3,600USD£2,875GBP
- Report
- March 2024
- 149 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- July 2023
- 110 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3327EUR$3,500USD£2,795GBP
- Report
- February 2024
- 116 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- October 2023
- 145 Pages
Global
From €2995EUR$3,150USD£2,516GBP
- Report
- November 2023
- 167 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- February 2024
- 115 Pages
Global
From €4516EUR$4,750USD£3,794GBP

The Pediatric Vaccine market is a subset of the larger Vaccine market, which focuses on the development and distribution of vaccines for children. Vaccines are a critical tool in the prevention of infectious diseases, and the pediatric vaccine market is a key component of the global effort to reduce the burden of disease in children. Vaccines are typically administered to children at a young age, and the pediatric vaccine market is focused on providing safe and effective vaccines to protect children from a variety of diseases.
The pediatric vaccine market is highly regulated, with stringent safety and efficacy standards in place to ensure the safety of the vaccines. Vaccines are typically developed and tested in clinical trials before being approved for use in children. Vaccines are also subject to ongoing monitoring and surveillance to ensure their continued safety and effectiveness.
The pediatric vaccine market is highly competitive, with a number of companies involved in the development and distribution of vaccines. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more